遗传检测：初级保健提供者的同意和结果披露。
Genetic Testing: Consent and Result Disclosure for Primary Care Providers.
机构信息
Office of the Chief Scientific Officer, Geisinger, MC 30-42, 100 North Academy Avenue, Danville, PA 17822, USA.
Center for Newborn Screening, Ethics, and Disability Studies, RTI International, 3040 East Institute Drive, Research Triangle Park, NC 27709, USA.
出版信息
Med Clin North Am. 2019 Nov;103(6):967-976. doi: 10.1016/j.mcna.2019.07.001. Epub 2019 Aug 20.
Abstract
Historically, both pretest and posttest genetic counseling has been standard of care for genetic testing. This model should be adapted for primary care providers (PCPs) willing to learn critical information about the test and key concepts that patients need to make an informed testing decision. It is helpful for PCPs to discuss a few initial patients with a genetic counselor to prepare for the key concepts of pretest and posttest counseling. This article provides guidance about the recommended level of involvement of PCPs based on the test indication, test complexity, disorder management, and the potential for psychosocial sequela.
摘要
从历史上看，检测前和检测后遗传咨询一直是遗传检测的标准护理。这种模式应该适用于愿意学习有关测试的关键信息和患者做出知情测试决策所需的关键概念的初级保健提供者（PCP）。对于 PCP 来说，与遗传咨询师讨论几个初始患者以准备检测前和检测后咨询的关键概念是有帮助的。本文根据测试指征、测试复杂性、疾病管理以及潜在的心理社会后果，提供了关于 PCP 参与程度的建议指南。
相似文献
1
Genetic Testing: Consent and Result Disclosure for Primary Care Providers.遗传检测：初级保健提供者的同意和结果披露。
Med Clin North Am. 2019 Nov;103(6):967-976. doi: 10.1016/j.mcna.2019.07.001. Epub 2019 Aug 20.
2
Developing a conceptual, reproducible, rubric-based approach to consent and result disclosure for genetic testing by clinicians with minimal genetics background.为有较少遗传学背景的临床医生制定一个概念上、可重复的、基于评分表的遗传检测同意书和结果披露方法。
Genet Med. 2019 Mar;21(3):727-735. doi: 10.1038/s41436-018-0093-6. Epub 2018 Jul 6.
3
Defining the Critical Components of Informed Consent for Genetic Testing.界定基因检测知情同意的关键组成部分。
J Pers Med. 2021 Dec 5;11(12):1304. doi: 10.3390/jpm11121304.
4
Committee Opinion No. 693 Summary: Counseling About Genetic Testing and Communication of Genetic Test Results.第693号委员会意见摘要：基因检测咨询与基因检测结果的传达
Obstet Gynecol. 2017 Apr;129(4):771-772. doi: 10.1097/AOG.0000000000002011.
5
Defining critical educational components of informed consent for genetic testing: views of US-based genetic counselors and medical geneticists.确定遗传检测知情同意中关键教育内容的定义：美国遗传咨询师和医学遗传学家的观点。
Eur J Hum Genet. 2023 Oct;31(10):1165-1174. doi: 10.1038/s41431-023-01401-0. Epub 2023 Jun 12.
6
Committee Opinion No. 693: Counseling About Genetic Testing and Communication of Genetic Test Results.第693号委员会意见：基因检测咨询与基因检测结果的传达
Obstet Gynecol. 2017 Apr;129(4):e96-e101. doi: 10.1097/AOG.0000000000002020.
7
American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.美国临床肿瘤学会政策声明更新：癌症易感性基因检测
J Clin Oncol. 2003 Jun 15;21(12):2397-406. doi: 10.1200/JCO.2003.03.189. Epub 2003 Apr 11.
8
Informed consent and the misattributed paternity problem in genetic counseling.遗传咨询中的知情同意与父子关系误认问题。
Bioethics. 2007 Jan;21(1):41-50. doi: 10.1111/j.1467-8519.2007.00522.x.
9
Application of a framework to guide genetic testing communication across clinical indications.应用框架指导跨临床适应证的遗传检测沟通。
Genome Med. 2021 Apr 29;13(1):71. doi: 10.1186/s13073-021-00887-x.
10
Genetic counseling and testing for breast-ovarian cancer susceptibility: what do women want?乳腺癌-卵巢癌易感性的遗传咨询与检测：女性想要什么？
J Clin Oncol. 1998 Jan;16(1):133-8. doi: 10.1200/JCO.1998.16.1.133.
引用本文的文献
1
and in precision oncology: Clinical implications for HRD associated breast and ovarian cancers (Review).以及在精准肿瘤学中：与同源重组缺陷（HRD）相关的乳腺癌和卵巢癌的临床意义（综述）
Int J Oncol. 2025 Aug;67(2). doi: 10.3892/ijo.2025.5771. Epub 2025 Jul 4.
2
Chatbot for the Return of Positive Genetic Screening Results for Hereditary Cancer Syndromes: Prompt Engineering Project.遗传性癌症综合征阳性基因筛查结果返回的聊天机器人：提示工程设计项目
JMIR Cancer. 2025 Jun 10;11:e65848. doi: 10.2196/65848.
3
Laboratory medicine between technological innovation, rights safeguarding, and patient safety: A bioethical perspective.技术创新、权利保障与患者安全之间的检验医学：生物伦理学视角
Open Med (Wars). 2025 May 29;20(1):20251153. doi: 10.1515/med-2025-1153. eCollection 2025.
4
The case for integrating genetic counselors into primary care: A paradigm shift for our profession.将遗传咨询师纳入初级保健的理由：我们这个职业的范式转变。
J Genet Couns. 2025 Jun;34(3):e70051. doi: 10.1002/jgc4.70051.
5
Chatbot for the Return of Positive Genetic Screening Results for Hereditary Cancer Syndromes: a Prompt Engineering Study.用于遗传性癌症综合征阳性基因筛查结果反馈的聊天机器人：一项提示工程研究
Res Sq. 2024 Aug 29:rs.3.rs-4986527. doi: 10.21203/rs.3.rs-4986527/v1.
6
Looking for RET alterations in thyroid cancer: clinical relevance, methodology and timing.寻找甲状腺癌中的 RET 改变：临床意义、方法和时机。
Endocrine. 2023 Aug;81(2):206-215. doi: 10.1007/s12020-023-03368-w. Epub 2023 May 17.
7
Barriers, interventions, and recommendations: Improving the genetic testing landscape.障碍、干预措施及建议：改善基因检测现状
Front Digit Health. 2022 Nov 1;4:961128. doi: 10.3389/fdgth.2022.961128. eCollection 2022.
8
Application of a framework to guide genetic testing communication across clinical indications.应用框架指导跨临床适应证的遗传检测沟通。
Genome Med. 2021 Apr 29;13(1):71. doi: 10.1186/s13073-021-00887-x.
9
Patient-Reported Outcomes and Experiences with Population Genetic Testing Offered Through a Primary Care Network.患者报告的通过初级保健网络提供的群体遗传检测的结果和体验。
Genet Test Mol Biomarkers. 2021 Feb;25(2):152-160. doi: 10.1089/gtmb.2020.0275.
本文引用的文献
1
Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast/ovarian cancer using the ACMG/AMP 2015 guidelines.采用 ACMG/AMP 2015 指南重新解读遗传性乳腺癌/卵巢癌患者中意义未明的 BRCA1 和 BRCA2 变异。
Breast Cancer. 2019 Jul;26(4):510-519. doi: 10.1007/s12282-019-00951-w. Epub 2019 Feb 6.
2
Patients' perspectives of variants of uncertain significance and strategies for uncertainty management.患者对意义未明变异的看法及不确定性管理策略。
J Genet Couns. 2019 Apr;28(2):313-325. doi: 10.1002/jgc4.1075. Epub 2019 Jan 12.
3
Developing a conceptual, reproducible, rubric-based approach to consent and result disclosure for genetic testing by clinicians with minimal genetics background.为有较少遗传学背景的临床医生制定一个概念上、可重复的、基于评分表的遗传检测同意书和结果披露方法。
Genet Med. 2019 Mar;21(3):727-735. doi: 10.1038/s41436-018-0093-6. Epub 2018 Jul 6.
4
Emotional impact on the results of BRCA1 and BRCA2 genetic test: an observational retrospective study.情绪对BRCA1和BRCA2基因检测结果的影响：一项观察性回顾性研究。
Hered Cancer Clin Pract. 2017 Oct 2;15:16. doi: 10.1186/s13053-017-0077-6. eCollection 2017.
5
Clinical penetrance in hereditary hemochromatosis: estimates of the cumulative incidence of severe liver disease among HFE C282Y homozygotes.遗传性血色素沉着症的临床外显率：HFE C282Y 纯合子发生严重肝脏疾病的累积发病率估计。
Genet Med. 2018 Apr;20(4):383-389. doi: 10.1038/gim.2017.121. Epub 2017 Aug 3.
6
Prevalence of Sickle Cell Trait and Reliability of Self-Reported Status among Expectant Parents in Nigeria: Implications for Targeted Newborn Screening.尼日利亚准父母中镰状细胞性状的患病率及自我报告状况的可靠性：对新生儿靶向筛查的影响
Public Health Genomics. 2016;19(5):298-306. doi: 10.1159/000448914. Epub 2016 Sep 10.
7
Psychological Distress, Anxiety, and Depression of Cancer-Affected BRCA1/2 Mutation Carriers: a Systematic Review.癌症相关BRCA1/2突变携带者的心理困扰、焦虑和抑郁：一项系统综述
J Genet Couns. 2016 Oct;25(5):880-91. doi: 10.1007/s10897-016-9949-6. Epub 2016 Apr 14.
8
Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents.需考虑的要点：儿童和青少年基因检测的伦理、法律及社会心理影响
Am J Hum Genet. 2015 Jul 2;97(1):6-21. doi: 10.1016/j.ajhg.2015.05.022.
9
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.序列变异解读的标准与指南：美国医学遗传学与基因组学学会和分子病理学协会的联合共识推荐
Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.
10
Variants of unknown significance in BRCA testing: impact on risk perception, worry, prevention and counseling.BRCA 检测中意义不明的变异：对风险感知、担忧、预防和咨询的影响。
Ann Oncol. 2013 Nov;24 Suppl 8:viii69-viii74. doi: 10.1093/annonc/mdt312.
Zotero 插件